Exosomes: Smart nanospheres for drug delivery naturally produced by stem cells

Fabrication and Self-Assembly of Nanobiomaterials: Applications of Nanobiomaterials

Volumn , Issue , 2016, Pages 179-209

  Maguire, Greg ^a  

^a The SRM Living Foundry and BioRegenerative Sciences   (United States)

Author keywords

Drug delivery vehicle; Exosome; Liposome; Nanoparticle; Protein payload; SRM; Stem cell; Stem cell released molecules; Synthetic biology; Systems therapeutic

Indexed keywords

CELL SIGNALING; CONTROLLED DRUG DELIVERY; CYTOLOGY; LIPID BILAYERS; LIPOSOMES; MOLECULAR BIOLOGY; MOLECULES; NANOPARTICLES; NANOSPHERES; PROTEINS; STEM CELLS;

BIOLOGICAL PROPERTIES; CONTROLLED MANIPULATIONS; DRUG DELIVERY SYSTEM; DRUG DELIVERY VEHICLES; EXOSOME; PHARMACEUTICAL DELIVERY; SYNTHETIC BIOLOGY; TRANS-MEMBRANE PROTEINS;

TARGETED DRUG DELIVERY;

EID: 84967154718     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-41533-0.00007-6     Document Type: Chapter

References (102)

1. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011, 29(4):341-345. http://dx.doi.org/10.1038/nbt.1807.
2. Armstead A.L., Li B. Nanomedicine as an emerging approach against intracellular pathogens. Int. J. Nanomed. 2011, 6:3281-3293.
3. Atay S., Gercel-Taylorb C., Kesimerc M., Taylor D.D. Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. Exp. Cell Res 2011, http://dx.doi.org/10.1016/j.yexcr.2011.01.014.
4. Bang C., Batkai S., Dangwal S., Gupta S.K., Foinquinos A., Holzmann A., et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 2014, 124(5):2136-2146. http://dx.doi.org/10.1172/JCI70577.
5. Barthlott W., Ehler N. Raster-Elektronenmikroskopie der Epidermis-Oberflachen von Spermatophyten. Trop. Subtrop. Pflanzenwelt 1977, 19:367-467.
6. Bellingham S.A., Guo B.B., Coleman B.M., Hill A.F. Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?. Front. Physiol 2012, doi:10.3389/fphys.2012.00124.
7. Bhat R., Bissell M.J. Of plasticity and specificity: dialectics of the micro- and macro-environment and the organ phenotype. Wiley Interdiscip. Rev. Membr. Transp. Signal. 2014, 3(2):147-163.
8. Byeon Y.E., Ryu H.H., Park S.S., Koyama Y., Kikuchi M., et al. Paracrine effect of canine allogenic umbilical cord blood-derived mesenchymal stromal cells mixed with beta-tricalcium phosphate on bone regeneration in ectopic implantations. Cytotherapy 2010, 12:626-636. http://dx.doi.org/10.3109/14653249.2010.481665.
9. Cai H., Reinisch K., Ferro-Novick S. Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle. Dev. Cell 2007, 12(5):671-682.
10. Carayon K., Chaoui K., Ronzier E., Lazar I., Bertrand-Michel J., Roques V, et al. Proteolipidic composition of exosomes changes during reticulocyte maturation. J. Biol. Chem. 2011, 286(39):34426-34439.
11. Chen T.S., Lai R.C., Lee M.M., Choo A.B., Lee C.N., Lim S.K. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2010, 38:215-224. http://dx.doi.org/10.1093/nar/gkp857.
12. Chen T.S., et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J. Transl. Med. 2011, 9:47-57.
13. Clayton A., Turkes A., Dewitt S., Steadman R., Mason M.D., Hallett M.B. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J. 2004, 18:977-979.
14. Clayton A., Mitchell J.P., Court J., Linnane S., Mason M.D., Tabi Z. Human tumor-derived exosomes down-modulate NKG2D expression. J. Immunol. 2008, 180(11):7249-7258.
15. Cretoiu D., Cretoiu S.M., Simionescu A.A., Popescu L.M. Telocytes, a distinct type of cell among the stromal cells present in the lamina propria of jejunum. Histol. Histopathol. 2012, 27:1067-1078.
16. Cretoiu S.M., Cretoiu D., Popescu L.M. Human myometrium-the ultrastructural 3D network of telocytes. J. Cell. Mol. Med. 2012, 16:2844-2849.
17. de Gennes Pierre-Gilles, Brochard-Wyart Françoise, Quéré David Capillarity and Wetting Phenomena 2004, Springer, New York.
18. Dear J.W., Street J.M., Bailey M.A. Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intra-renal signaling. Proteomics 2012, doi:10.1002/pmic.201200285.
19. Dettre R.H., Johnson R.E.J. Contact angle hysteresis: II. Contact angle measurements on rough surfaces Contact S132. The dream of staying clean: lotus and biomimetic surfaces. Angle, Wettability, and Adhesion 1964, 136-144. American Chemical Society, Washington, DC. F.M. Fowkes (Ed.).
20. Duijvesz D., Burnum-Johnson K.E., Gritsenko M.A., Hoogland A.M., Vredenbregt-van den Berg M.S., Willemsen R., et al. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PLoS One 2013, 8(12):e82589. http://dx.doi.org/10.1371/journal.pone.0082589.
21. Duijvesz D., Luider T., Bangma C.H., Jenster G. Exosomes as biomarker treasure chests for prostate cancer. Eur. Urol. 2011, 59:823-831.
22. Ekström K., Valadi H., Sjöstrand M., Malmhäll C., Bossios A., et al. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J. Extracell. Vesicles 2012, 1. http://dx.doi.org/10.3402/jev.v1i0.18389.
23. Erickson H.P. Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biol. Proced. Online 2009, 11:32-51. http://dx.doi.org/10.1007/s12575-009-9008-x.
24. Faure J., Lachenal G., Court M., Hirrlinger J., Chatellard-Causse C., Blot B., et al. Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 2006, 31:642-648.
25. Feynman R. There's plenty of room at the bottom. J. Microeleciromech. Syst. 1992, 1(i):60-66.
26. Furstner R., Barthlott W., Neinhuis C., Walzel P. Wetting and self-cleaning properties of artificial superhydrophobic surfaces. Langmuir 2005, 21:956-961.
27. Gallo A., Tandon M., Alevizos I., Illei G.G. The majority of micrornas detectable in serum and saliva is concentrated in exosomes. PLoS One 2012, 7:e30679.
28. Gittes F., Mickey B., Nettleton J., Howard J. Flexural rigidity of microtubules and actin filaments measured from thermal fluctuations in shape. J. Cell Biol. 1993, 120:923-934. http://dx.doi.org/10.1083/jcb.120.4.923.
29. Gradilla A.C., et al. Exosomes as Hedgehog carriers in cytoneme-mediated transport and secretion. Nat. Commun. 2014, 5:5649. http://dx.doi.org/10.1038/ncomms6649.
30. Haines B.L., Jernstedt J.A., Neufeld H.S. Direct foliar effects of simulated acid rain II. leaf surface characteristics. New Phytol. 1985, 99:407-416. http://dx.doi.org/10.1111/j.1469-8137.1985.tb03668.
31. Haynesworth S.E., Baber M.A., Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1α. J. Cell. Physiol. 1996, 166:585-592.
32. Hao S., Bai O., Li F., Yuan J., Laferte S., Xiang J. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity. Immunology 2007, 120(1):90-102.
33. Herminghaus S. Roughness-induced non-wetting. EDP Sciences • EPL (Europhys. Lett.) 2000, 52(2).
34. Huang L., Ma W., Ma Y., Feng D., Chen H., Cai B. Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?. Int. J. Biol. Sci. 2015, 11(2):238-245.
35. Hung M.E., Leonard J.N. Stabilization of exosome targeting peptides via engineered glycosylation. J. Biol. Chem. 2015, Feb 5. pii: jbc.M114.621383. [Epub ahead of print].
36. Hurley J.H., Odorizzi G. Get on the exosome bus with alix. Nat. Cell Biol. 2012, 14:654-655.
37. Johannsen W.L. The genotype conception of heredity. Am. Nat. 1911, 45:129-159.
38. Karlsson M., Lundin S., Dahlgren U., Kahu H., Petterson I., Telemo E. "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 2001, 31:2892-2900.
39. Kato T., et al. Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res. Ther. 2014, 16:R163. http://dx.doi.org/10.1186/ar4679.
40. Ko S., Yip H.-K., Zhen Y.-Y., et al. Adipose-derived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model: apparent diffusion coefficient, natural killer T-cell responses, and histopathological features. Stem Cells Int. 2015, 2015. Article ID 853506.
41. Kraft J.C., Freeling J.P., Wang Z., Ho R.J.Y. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J. Pharm. Sci. 2014, 103:29-52.
42. Lai Y., Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30:131-141.
43. Lai R.C., Arslan F., Lee M.M., Sze N.S., Choo A., Chen T.S. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010, 4:214-222.
44. Lee J.K., Park S.R., Jung B.K., Jeon Y.K., Lee Y.S., Kim M.K., et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One 2013, 8(12):e84256. http://dx.doi.org/10.1371/journal.pone.0084256.
45. Lugini L., Cecchetti S., Huber V., Luciani F., Macchia G., Spadaro F., et al. Immune surveillance properties of human NK cell-derived exosomes. J. Immunol. 2012, 189:2833-2842.
46. Luesma M.J., Gherghiceanu M., Popescu L.M. Telocytes and stem cells in limbus and uvea of mouse eye. J. Cell. Mol. Med. 2013, 17:1016-1024. http://dx.doi.org/10.1111/jcmm.12111.
47. Maguire G. Using a systems-based approach to overcome reductionist strategies in the development of diagnostics. Expert Rev. Mol. Diagn. 2013, 13(8):895-905.
48. Maguire G. Stem cell therapy without the cells. Commun. Integr. Biol. 2013, 6(6):e26631.
49. Maguire G. Systems biology approach to developing "systems therapeutics". ACS Med. Chem. Lett. 2014, 5(5):453-455. http://dx.doi.org/10.1021/ml5000614.
50. Maguire G. Maturing from embryonic to adult policy on stem cell therapeutics. ACS Med. Chem. Lett. 2014, 5(12):1264-1265. http://dx.doi.org/10.1021/ml500396z.
51. Maguire G., Friedman P. Systems biology approach to developing S2RM-based "systems therapeutics" and NiPSs. World J. Stem Cells 2015, 7:745-756.
52. Maguire G., Friedman P., McCarthy D., Friedman R., Maniotis A. Stem cell released molecules and exosomes in tissue engineering. Procedia Eng. 2013, 59:270-278. http://dx.doi.org/10.1016/j.proeng.2013.05.121.
53. Makino D.L., Halbach F., Conti E. The RNA exosome and proteasome: common principles of degradation control. Nat. Rev. Mol. Cell Biol. 2013, 14(10):654-660. http://dx.doi.org/10.1038/nrm3657.
54. Mallipeddi R., Rohan L.C. Nanoparticle-based vaginal drug delivery systems for HIV prevention. Expert Opin. Drug Deliv. 2010, 7(1):37-48.
55. Marmur A. Super-hydrophobicity fundamentals: implications to biofouling prevention. Biofouling 2006, 22:107-115.
56. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012, 40:D1241-D1244.
57. Mathivanan S., Lim J.W.E., Tauro B.J., Ji H., Moritz R.L., Simpson R.J. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 2010, 9(2):197-208.
58. Mead, C., 2013. The Nature of Light: What are "Photons"? In: The Nature of Light: What are Photons? V. Proceedings of SPIE. No.8832. Society of Photo-Optical Instrumentation Engineers (SPIE), Bellingham, WA, Art. No. 883202. ISBN: 9780819496829 <>. http://resolver.caltech.edu/CaltechAUTHORS:20131209-074730086.
59. Moore K.S., Wehrli S., Roder H., Rogers M., Forrest J.N., McCrimmon D., et al. Squalamine: an aminosterol antibiotic from the shark. Proc. Natl. Acad. Sci. USA 1993, 90(4):1354-1358. PMCID: PMC45871.
60. Nishino T., Meguro M., Nakamae K., Matsushita M., Ueda Y. The lowest surface free energy based on -CF3 alignment. Langmuir 1999, 15:4321-4323.
61. Noble D. The Music of Life 2006, Oxford University Press, Oxford, UK.
62. Ohno S., Takanashi M., Sudo K., Ueda S., Ishikawa A., Matsuyama N., et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 2013, 21:185-191.
63. Öner D., McCarthy T.J. Ultrahydrophobic surfaces. Effects of topography length scales on wettability. Langmuir 2000, 16(20):7777-7782.
64. Pant S., Hilton H., Burczynski M.E. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem. Pharmacol. 2012, 83:1484-1494.
65. Parolini I., Federici C., Raggi C., Lugini L., Palleschi S., de Milito A., et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 2009, 284:34211-34222.
66. Patankar N.A. Mimicking the lotus effect: influence of double roughness structures and slender pillars. Langmuir 2004, 20(19):8209-8213.
67. Petersen S.H., Odintsova E., Haigh T.A., Rickinson A.B., Taylor G.S., Berditchevski F. The role of tetraspanin CD63 in antigen presentation via MHC class II. Eur. J. Immunol. 2011, 41:2556-2561.
68. Ramteke A., Ting H., Agarwal C., Mateen S., Somasagara R., Hussain A., et al. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol. Carcinog 2013, http://dx.doi.org/10.1002/mc.22124.
69. Raposo G., Nijman H., Stoorvogel W., Liejendekker R., Harding C., Melief C., et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183:1161-1172.
70. Ratajczak J., Miekus K., Kucia M., Zhang J., Reca R., Dvorak P., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006, 20:847-856.
71. Reese T.S., Morris K. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 1967, 34(1):207-217. http://dx.doi.org/10.1083/jcb.34.1.207.
72. Richards F.M. The interpretation of protein structures: total volume, group volume distributions and packing density. J. Mol. Biol. 1974, 82:1-14.
73. Riches A., Campbell E., Borger E., Powis S. Regulation of exosome release from mammary epithelial and breast cancer cells-a new regulatory pathway. Eur. J. Cancer. 2014, 50(5):1025-1034. http://dx.doi.org/10.1016/j.ejca.2013.12.019.
74. Rubin L.L., Staddon J.M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 1999, 22(1):11-28. http://dx.doi.org/10.1146/annurev.neuro.22.1.11.
75. Sahoo S., Klychko E., Thorne T., Misener S., Schultz K.M., Millay M., et al. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ. Res. 2011, 109:724-728.
76. Sandvig K., Llorente A. Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3. Mol. Cell. Proteomics 2012, 11(7). M111.012914.
77. Savina A., Furlan M., Vidal M., Colombo M.I. Exosome release is regulated by a calcium-dependent mechanism in k562 cells. J. Biol. Chem. 2003, 278:20083-20090.
78. Savina A., Fader C.M., Damiani M.T., Colombo M.I. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 2005, 6:131-143.
79. + dendritic cells use lfa-1 to capture MHC-peptide complexes from exosomes in vivo. J. Immunol. 2007, 179:1489-1496.
80. Seke Etet P.F., Vecchio L., Nwabo Kamdje A.H. Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment. Cell. Signal. 2012, 24:1883-1888. http://dx.doi.org/10.1016/j.cellsig.2012.05.015.
81. Shen B., Wu N., Yang J.M., Gould S.J. Protein targeting to exosomes/microvesicles by plasma membrane anchors. J. Biol. Chem. 2011, 286:14383-14395.
82. Siegel L.M., Monty K.J. Biochim. Biophys. Acta 1966, 112:346-362.
83. Skriner K., Adolph K., Jungblut P., Burmester G. Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 2006, 54:3809-3814.
84. Sprent J. Direct stimulation of naive T cells by antigen-presenting cell vesicles. Blood Cells Mol. Dis. 2005, 35:17-20.
85. Suntres Z.E., Smith M.G., Momen-Heravi F., Hu J., Zhang X., Wu Y., et al. Therapeutic uses of exosomes. Intech 2013, doi:10.5772/56522.
86. Tan A., De La Pena H., Seifalian A.M. The application of exosomes as a nanoscale cancer vaccine. Int. J. Nanomed. 2010, 5:889-900.
87. Tan S.S., Yin Y., Lee T., Lai R.C., Yeo R.W., et al. Therapeutic MSC exosomes are derived rom lipid raft microdomains in the plasma membrane. J. Extracell. Vesicles 2013, 2. http://dx.doi.org/10.3402/jev.v2i0.22614.
88. Thormar H., Hilmarsson H., Bergsson G. Antimicrobial lipids: role in innate immunity and potential use in prevention and treatment of infections. Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education 2013, vol. 3:1474-1488. Formatex, Badajoz, Spain, ISBN: 978-84-942134-1-0.
89. Tian Y., Li S., Song J., Ji T., Zhu M., Anderson G.J., et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 2014, 35:2383-2390.
90. Torregrosa Paredes P., Esser J., Admyre C., Nord M., Rahman Q.K., Lukic A., et al. Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy 2012, 67:911-919.
91. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319(5867):1244-1247.
92. Veron P., Segura E., Sugano G., Amigorena S., Thery C. Accumulation of MFGE8/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol. Dis. 2005, 35:81-88.
93. Wahlgren J., de Karlson L.T., Brisslert M., vaziri Sani F., Telemo E., Sunnerhagen P., et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res. 2012, 40:e130.
94. Xin H., Li Y., Cui Y., Yang J.J., Zhang Z.G., Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cerebral Blood Flow Metab. 2013, 33:1711-1715. PMID: 23963371.
95. Yeaman M.R., Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55(1):27-55.
96. Yoshioka Y., et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat. Commun. 2014, 5. http://dx.doi.org/10.1038/ncomms4591.
97. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 1987, 84(15):5449-5453. PMCID: PMC298875.
98. Zeelenberg I.S., Ostrowski M., Krumeich S., Bobrie A., Jancic C., Boissonnas A., et al. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. Cancer Res. 2008, 68:1228-1235.
99. Zhang H.C., Liu X.B., Huang S., Bi X.Y., Wang H.X., et al. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev. 2012, 21:3289-3297.
100. Zhang Y., et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J. Neurosurg 2015, doi:10.3171/2014.11.JNS14770.
101. Zhou H., Yuen P.S.T., Pisitkun T., et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int. 2006, 69:1471-1476.
102. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat. Rev. Cancer 2009, 9:40-55.